
T2 Biosystems TTOO
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
T2 Biosystems ROCE 2011-2026 | TTOO
ROCE Jährlich T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 177.14 | 139.19 | 333.05 | -59.7 | 162.25 | -375.37 | -1749.01 | -63.85 | -58.1 | -41.48 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 333.05 | -1749.01 | -153.59 |
ROCE Vierteljährlich T2 Biosystems
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 353.21 | 337.17 | 210.66 | 134.01 | 183.9 | 163.05 | 167.25 | 147.84 | 643.66 | 1089.59 | 929.9 | 2090.29 | 1968.41 | 1350.7 | 1369.06 | -378.59 | -342.22 | -184.03 | -42.19 | 153.09 | -2.66 | -119.53 | -255.68 | -395.98 | -1348.69 | -2196.25 | -3138.26 | -4018.81 | -2979.53 | -2081.76 | -1077.96 | -129.34 | -121.12 | -114.54 | -103.15 | -92.42 | -84.5 | -75.41 | -66.48 | -57.89 | -34.91 | -15.15 | 3.82 | 16.85 | 10.56 | 5.48 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2090.29 | -4018.81 | -176.71 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
25.0 | $ 114.87 | -0.65 % | $ 34.9 B | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 1.61 | -2.35 % | $ 2.14 M | ||
|
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
1.9 | $ 24.61 | -1.48 % | $ 684 M | ||
|
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 21.85 | - | $ 1.16 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
Illumina
ILMN
|
-35.1 | $ 126.55 | -1.54 % | $ 20.1 B | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 15.29 | -1.99 % | $ 462 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
28.52 | $ 83.38 | -0.87 % | $ 5.63 B | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 166.76 | -2.61 % | $ 8.27 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
440.3 | $ 82.62 | -6.64 % | $ 10.4 B | ||
|
National Research Corporation
NRC
|
161.47 | $ 16.99 | -0.73 % | $ 380 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
18.26 | $ 1.93 | - | $ 8.54 M | ||
|
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.13 | -1.49 % | $ 20 B | ||
|
Precipio
PRPO
|
-8.25 | $ 30.2 | -1.64 % | $ 48.5 M | ||
|
Personalis
PSNL
|
-33.64 | $ 5.54 | -7.05 % | $ 328 M | ||
|
Senseonics Holdings
SENS
|
-111.94 | $ 7.28 | 0.14 % | $ 304 M | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 416.18 | -1.23 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
-125.14 | $ 2.13 | -2.06 % | $ 4.89 M | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 101.17 | -1.98 % | $ 8.34 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 261.16 | -0.86 % | $ 21.7 B | ||
|
Thermo Fisher Scientific
TMO
|
14.5 | $ 469.03 | 0.21 % | $ 177 B | ||
|
Trinity Biotech plc
TRIB
|
0.08 | $ 0.62 | -3.8 % | $ 61.9 M | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 9.29 | -1.75 % | $ 2.01 B | ||
|
Celcuity
CELC
|
-171.24 | $ 122.03 | -2.9 % | $ 5.71 B | ||
|
Twist Bioscience Corporation
TWST
|
-28.81 | $ 59.4 | -2.62 % | $ 3.55 B | ||
|
NeoGenomics
NEO
|
-9.11 | $ 8.67 | 0.7 % | $ 1.11 B | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 4.83 | -0.1 % | $ 447 M | ||
|
Natera
NTRA
|
-76.66 | $ 199.57 | -2.36 % | $ 19.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 196.11 | -0.26 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M |